Creates provisions relating to pharmacists' authority to dispense insulin
Summary
HB1188 revises Missouri’s pharmacy law to expressly authorize pharmacists to dispense an emergency supply of insulin to a patient without a current valid prescription, so long as specified conditions are met. Those conditions include a reasonable but unsuccessful attempt to contact the prescriber, evidence of a recent prescription or the pharmacist’s professional judgment that withholding insulin would endanger the patient or disrupt essential chronic therapy, dispensing no more than the most recent prescription or standard unit-of-use quantity, and no indication from the prescriber that emergency refills are prohibited.
The bill also amends the definition of the “practice of pharmacy” to include dispensing an emergency supply of insulin and makes related conforming changes to pharmacy practice statutes. It preserves existing limits on pharmacists’ authority, including that pharmacists may not independently diagnose or prescribe pharmaceuticals except as specifically allowed, and it directs the Board of Pharmacy to adopt rules, in consultation with other licensing boards, to establish standard procedures and documentation requirements for emergency insulin dispensing. The bill also includes liability protections for pharmacists, their employers, and original prescribers unless negligence, recklessness, or willful or wanton misconduct is involved.
Impact
HB1188 would amend Chapter 338, RSMo, by repealing section 338.010 and enacting new sections 338.010 and 338.740. The practical effect is to expand the scope of pharmacy practice to include emergency insulin dispensing and to create a new statutory framework governing when and how pharmacists may provide insulin without a current prescription. It also requires rulemaking by the Board of Pharmacy, with input from the healing arts and nursing boards, and establishes documentation and procedural standards for these emergency fills.
Sentiment
Based on the bill text and the absence of recorded committee testimony or votes, the measure appears to be framed as a patient-access and continuity-of-care bill, with a generally supportive policy posture toward preventing insulin interruptions. The structure of the bill suggests an effort to balance access with safeguards, indicating a likely pragmatic rather than ideological approach. No formal vote history or transcript comments are available to show opposition or support from specific legislators or stakeholders.
Contention
The main points of potential contention are the expansion of pharmacists’ authority, the conditions under which insulin may be dispensed without a valid prescription, and the scope of liability protection. Pharmacists and patient advocates would likely support the emergency access provision, while prescribers or regulators may focus on concerns about oversight, documentation, and whether the emergency-dispensing standard is sufficiently narrow. The bill also leaves rulemaking details to the Board of Pharmacy and related boards, which could raise questions about how much discretion those agencies should have in setting procedures.